Robert

Robert "Pete" Pullen, Ph.D. Email and Phone Number

Owner @ Panama City Beach, FL, US
Panama City Beach, FL, US
Robert "Pete" Pullen, Ph.D.'s Location
Panama City Beach, Florida, United States, United States
Robert "Pete" Pullen, Ph.D.'s Contact Details

Robert "Pete" Pullen, Ph.D. work email

Robert "Pete" Pullen, Ph.D. personal email

n/a
About Robert "Pete" Pullen, Ph.D.

Pharmaceutical Industry Leader with expertise leading large scientific/technical organizations responsible for analytical development, launch, and commercial support for internal and external manufacturing. Known for ability to direct complex programs and consistently achieve deliverables for scope, time and budget. Will apply his analytical expertise, unique breadth of experience, and ability to consistently achieve project deliverables to fulfill client analytical, CMC, or laboratory project needs.ANALYTICAL DEVELOPMENT. Analytical method and specification development expertise to support formulation development, clinical development and marketed product needs. Phase-appropriate method validation solutions and reports.CMC SUBMISSIONS. Author CMC sections for investigational new drug submissions, marketing applications, and post-approval CMC submissions. Technical briefing package preparation and SME representation at FDA meetings.STABILITY STUDIES. Protocol design and preparation for excipient compatibility, forced degradation, research, clinical, registration and marketed product stability studies. Data analysis and study reports.TECHNOLOGY TRANSFER. Experience directing analytical method transfers from internal development to internal manufacturing, CRO to CMO, and CMO to CMO. Manage CRO / CMO project interactions; serve as Technical Team lead/Steering Committee member.LABORATORY OPERATIONS. Partner with Analytical Development or Quality Control laboratory management to support lab expansions, LIMS implementations, staff skills assessments and technical career ladder development.Specialties: • Analytical Development • CMC Submissions• Technology Transfer • Stability• Program Management • Laboratory Operations

Robert "Pete" Pullen, Ph.D.'s Current Company Details
Robert

Robert "Pete" Pullen, Ph.D., Analytical Consulting |Analytical Development|Tech

Owner
Panama City Beach, FL, US
Robert "Pete" Pullen, Ph.D. Work Experience Details
  • Robert
    Owner
    Robert "Pete" Pullen, Ph.D., Analytical Consulting |Analytical Development|Tech
    Panama City Beach, Fl, Us
  • Robert
    Owner
    Robert "Pete" Pullen, Ph.D., Analytical Consulting |Analytical Development|Tech Transfer|Stability Jan 2012 - Present
    Baltimore, Maryland Area
    Offers Pharmaceutical Companies, Contract Research Organizations and Contract Manufacturing Organizations Analytical support services including:• Analytical Development • CMC Submissions • Stability • Tech Transfer • Program Management • Lab Operations Pete has over 29 years of Pharmaceutical industry experience in leadership and technical positions at Upjohn, ICI, Solvay and most recently, Shire Pharmaceuticals. During his 15 years at Shire, Pete led large scientific/technical organizations responsible for analytical development/QC, authoring CMC content, and providing technical support for internal and external manufacturing operations. He was a key player in the development and launch of multiple new products at Shire. Pete also directed commercial technology transfer at Shire, including the transfer of all products from Shire’s internal manufacturing site to a CMO. Pete will apply his analytical expertise, unique breadth of experience, and ability to consistently achieve project deliverables to fulfill client analytical, CMC, or laboratory project needs.
  • Shire Pharmaceuticals
    Vice President, Technology Transfer And Engineering
    Shire Pharmaceuticals Jan 2011 - Jan 2012
    Owings Mills, Md
    Technology Transfer Governance Team Leader for Shire’s Global Supply Chain (GSC). Managed Engineering and Maintenance at the 170,000 SF Owings Mills manufacturing site. On Leadership Team for the Owings Mills Plant and Global Pharmaceutical Technology.• Earned Recognition Award from the Global Supply Chain Leadership team for on-time completion of Technology Transfer of all products from Shire’s manufacturing facility to a CMO. • Led Transition Team for the Owings Mills plant closure program. Delivered 3 year program on target, for time, costs and deliverables. Achieved with a remarkably low rate of unexpected employee departures.
  • Shire Pharmaceuticals
    Vice President, Global Pharmaceutical Technology
    Shire Pharmaceuticals Jan 2007 - Dec 2010
    Owings Mills, Md
    Directed Pharmaceutical Analysis, Global Technical Services, Validation, and Process Improvement operations for the GSC. Led internal/external technology transfers, process optimization, technical services, validation execution, and associated laboratory support. Developed functional strategic initiatives, budget, training, manpower, capital and project plans for GPT. On the GSC Leadership Team; reported to Head of GSC for Shire’s $3B Specialty Pharma Business.• Sponsored Lean Six Sigma laboratory initiatives to optimize space, deliver 24-hour sample results and provide critical real-time data sharing to Manufacturing. • Completed technology transfer, registration and manufacturing validation to enable launch of VYVANSE capsules and Shire’s new ADHD drug INTUNIV from Owings Mills. • Project champion for 5 concurrent drug product technology transfer projects to Shire’s strategic manufacturing partner (24-month project). Met all key deliverables for time, cost and quality.• Sponsored creation of a commercial product characterization program and a dedicated team. Resulted in improved process controls and reduced batch failures for priority projects.
  • Shire Pharmaceuticals
    Vice President, Analytical Sciences
    Shire Pharmaceuticals Nov 2004 - Dec 2006
    Owings Mills, Md
    Led analytical staff of 55 in support of CMC submissions, technology transfers, manufacturing validation, and stability at Owings Mills and contract facilities. Oversaw Quality Control (chemistry and microbiology) release and marketed product stability for onsite commercial manufacturing.• Kept up with accelerated manufacturing demands by establishing a 2nd shift QC operation, raw materials testing group, and pharmaceutical analysis support for technology transfers.• Established Laboratory Services which provided dedicated support for data systems, calibration, stability and training. Lab operations passed FDA inspection in 2005 with no 483 observations.• Managed LIMS implementation project to improve lab efficiency and compliance. Delivered on-time and on-budget and project went live 9 months after kick-off.
  • Shire Laboratories Inc
    Vice President, Analytical Sciences
    Shire Laboratories Inc 1997 - 2004
    Rockville, Md
    Directed analytical support for methods and specification development, CMC submissions content, formulation, clinical supplies, stability studies and bioanalysis of developmental and marketed product dosage forms. Supported internal projects and programs for external clients. Led 50 personnel in Pharmaceutical Analysis, Laboratory Services and Bioanalytical Sciences.• Lead CMC role in 10 IND filings and 2 approved NDAs for CARBATROL (carbamazepine extended-release capsules) and ADDERALL XR (mixed amphetamine salts extended-release capsules). A 3rd development product, IINTUNIV, was approved in 2009.• Received annual employee Recognition Award for observation-free lab PAI and FDA approval for ADDERALL XR line extension, 2003.• Inspection co-lead for a successful PAI in February 2001 which concluded with FDA Investigator approval recommendation for ADDERALL XR NDA; Shire’s first blockbuster product.• Lead technical manager for 25 CMC supplements approved for changes which supported Shire’s rapid US growth. • Analytical Lead for Regulatory Agency meetings and teleconferences; answered Agency questions on analytical topics.• Sponsored upgrades of critical laboratory systems including software, automation, and instruments to deliver analytical and bioanalytical data for Shire Lab’s growing developmental pipeline.
  • Solvay Pharmaceuticals
    Director, Analytical Development
    Solvay Pharmaceuticals 1990 - 1997
    Marietta, Ga

Robert "Pete" Pullen, Ph.D. Skills

Analytical Development Cmc Submissions Stability Technology Transfer Laboratory Operations Program Management Validation Analytical Chemistry Laboratory Cmc Gmp Fda Regulatory Affairs Lims Pharmaceutical Industry 21 Cfr Part 11 Chemistry Quality Control Ind Cro Sop Regulatory Submissions Contract Manufacturing Quality System Drug Development

Robert "Pete" Pullen, Ph.D. Education Details

Frequently Asked Questions about Robert "Pete" Pullen, Ph.D.

What company does Robert "Pete" Pullen, Ph.D. work for?

Robert "Pete" Pullen, Ph.D. works for Robert "pete" Pullen, Ph.d., Analytical Consulting |analytical Development|tech

What is Robert "Pete" Pullen, Ph.D.'s role at the current company?

Robert "Pete" Pullen, Ph.D.'s current role is Owner.

What is Robert "Pete" Pullen, Ph.D.'s email address?

Robert "Pete" Pullen, Ph.D.'s email address is rp****@****zon.net

What schools did Robert "Pete" Pullen, Ph.D. attend?

Robert "Pete" Pullen, Ph.D. attended Georgia State University, Oglethorpe University, Western Michigan University.

What skills is Robert "Pete" Pullen, Ph.D. known for?

Robert "Pete" Pullen, Ph.D. has skills like Analytical Development, Cmc Submissions, Stability, Technology Transfer, Laboratory Operations, Program Management, Validation, Analytical Chemistry, Laboratory, Cmc, Gmp, Fda.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.